Back
NYLI Hedge Multi-Strategy Tracker ETF Vs. Rapt Therapeutics, Inc. Industry Stock Comparison
Sell
49
QAI
NYLI Hedge Multi-Strategy Tracker ETF
Last Price:
$33.52
Seasonality Move:
0.79%
Sell
38
RAPT
Rapt Therapeutics, Inc.
Last Price:
$33.91
Seasonality Move:
-28.15%
Sell
49
NYLI Hedge Multi-Strategy Tracker ETF (QAI)
is a Sell
Is NYLI Hedge Multi-Strategy Tracker ETF a Buy, Sell or Hold?
-
The current NYLI Hedge Multi-Strategy Tracker ETF [QAI] share price is $33.51. The Score for QAI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
QAI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Rapt Therapeutics, Inc. [RAPT] share price is $33.87. The Score for RAPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
RAPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
QAI Stock Price Chart
What is NYLI Hedge Multi-Strategy Tracker ETF's stock price today?
-
The NYLI Hedge Multi-Strategy Tracker ETF share price today is $33.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QAI is experiencing selling pressure, which indicates risk of future bearish movement.
RAPT Stock Price Chart
What is Rapt Therapeutics, Inc.'s stock price today?
-
The Rapt Therapeutics, Inc. share price today is $33.87Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing slight buying pressure.
QAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.4 | Buy |
| Relative Strength Index (14 RSI): | 37.67 | Sell |
| Chaikin Money Flow: | -79491 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.66 - 34.06) | Sell |
| Bollinger Bands (100): | (33.18 - 33.94) | Sell |
RAPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.53 | Buy |
| Relative Strength Index (14 RSI): | 51.15 | Buy |
| Chaikin Money Flow: | 79100 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.58 - 35.84) | Sell |
| Bollinger Bands (100): | (16.83 - 33.91) | Buy |
QAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.95 | Sell |
| 20-day SMA: | 33.92 | Sell |
| 50-day SMA: | 33.79 | Sell |
| 200-day SMA: | 32.67 | Buy |
| 8-day EMA: | 30.33 | Buy |
| 20-day EMA: | 20.13 | Buy |
| 50-day EMA: | 10.26 | Buy |
| 200-day EMA: | 2.92 | Buy |
RAPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35 | Sell |
| 20-day SMA: | 34.72 | Sell |
| 50-day SMA: | 31.71 | Buy |
| 200-day SMA: | 17.02 | Buy |
| 8-day EMA: | 31.84 | Buy |
| 20-day EMA: | 21.97 | Buy |
| 50-day EMA: | 11.45 | Buy |
| 200-day EMA: | 3.3 | Buy |
NYLI Hedge Multi-Strategy Tracker ETF Earnings Growth & QAI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rapt Therapeutics, Inc. Earnings Growth & RAPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and a decrease next year of $1.22 per share.
NYLI Hedge Multi-Strategy Tracker ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rapt Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||